Pharmacovigilance and Risk Management Strategies 2016

Discuss opportunities, challenges, and practical aspects of managing risk in the context of benefits, for medical product safety and pharmacovigilance.

返回 Agenda

Session 1 - Keynote Address

Session Chair(s)

William Gregory, PhD

Senior Director, Safety and Risk Management

Pfizer Inc, United States

Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP

Strategy

Consultant, United Kingdom

Session 1 - Keynote Address

Speaker(s)

Keynote - How Can Drug Safety Promote Innovation in Health Care?

Mark B. McClellan, MD, PhD

Duke-Margolis Center For Health Policy, United States

Director and Robert J. Margolis M.D. Professor of Business, Medicine and Policy

Pharmacovigilance and Risk Management Strategies 2016

Session 1 - Keynote Address

Session Chair(s)

William Gregory, PhD

Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP

Speaker(s)

Keynote - How Can Drug Safety Promote Innovation in Health Care?

获得信息并保持参与